ArticleEuropean child & adolescent psychiatry2026
Trends and incidence rates of neurodevelopmental disorders in Danish children and adolescents 2000-2024 : Short title: neurodevelopmental disorders in children and adolescents.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark.Basic & clinical pharmacology & toxicology · 2026Article
- Changes in incidence of hospital diagnoses of mental disorders among children and adolescents over the past 3 decades.BMJ mental health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) are prevalent neurodevelopmental disorders with long-term consequences. Recognition is essential but often delayed, particularly in females. Many cases are not captured in national registers, though many ADHD are often identifiable through prescriptions. We examined age- and sex-specific incidence and temporal trends in ASD and ADHD diagnosis in Denmark from 2000 to 2024 and assessed how including prescription data affects ADHD estimates.
methodsA cohort of all children residing in Denmark from 2000 to 2024 (n = 2.8 million) was followed until age 18 or December 31, 2024. Using nationwide registers, we identified diagnoses of ASD and ADHD. For ADHD, we extended the definition to include ADHD-specific prescriptions. We estimated age- and sex-specific incidence rates (IRs), cumulative incidence at each 1-year age point, and trends by birth cohort.
resultsAmong 2.8 million children, 60,432 were diagnosed with ASD and 102,051 with ADHD. Incidence rates increased for both conditions, with a steeper rise among females. By age 18, cumulative incidence was 6.5% (95% confidence intervals (CI) 6.5–6.6) in males and 3.9% (95% CI 3.8-4.0) in females for ASD, and 9.8% (95% CI 9.8–9.9) and 7.4% (95% CI 7.3–7.5) for ADHD. Although rates remained higher in males, the sex gap narrowed substantially, particularly for ADHD. Including ADHD-specific prescriptions raised cumulative ADHD incidence by age 18 from 6.9% (95% CI 6.8–6.9) to 8.7% (95% CI 8.6–8.7).
conclusionThe incidence of ASD and ADHD has risen substantially in Denmark over the past two decades, most pronounced among girls, narrowing the historical sex gap. Incorporating prescription data increased ADHD incidence estimates notably, underscoring the importance of broader case definitions in epidemiological research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.